(122 days)
Not Found
No
The document describes a medical image review workstation with standard image processing and display capabilities. There is no mention of AI, ML, or related terms, nor any description of training or test sets typically associated with AI/ML development. The focus is on image manipulation, display, and integration with existing systems and standards.
No.
The device is for reviewing and manipulating images for diagnostic purposes, not for treating or preventing disease.
Yes
The 'Intended Use / Indications for Use' section explicitly states that "MammoWorkstation is designed to assist radiologists in conducting primary diagnostic review for diagnostic and screening mammography." This indicates its role in the diagnostic process.
Yes
The device description explicitly states "It is a software product" and the functionality described (image review, manipulation, analysis, post-processing, reporting, teleradiology) is consistent with software-based image processing and management, without mentioning any dedicated hardware components included with the device. While it interacts with hardware (displays, storage devices), the device itself is presented as software.
Based on the provided information, the MammoWorkstation is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: IVD devices are used to examine specimens (like blood, urine, or tissue) taken from the human body to provide information about a person's health. This information is typically used for diagnosis, monitoring, or screening.
- MammoWorkstation's Function: The MammoWorkstation is a software workstation designed for the review and manipulation of medical images (specifically mammography images). It assists radiologists in interpreting these images for diagnostic and screening purposes. It does not analyze biological specimens.
The device description and intended use clearly indicate that its function is related to image processing and display for diagnostic interpretation by a radiologist, not the analysis of biological samples.
N/A
Intended Use / Indications for Use
MammoWorkstation is designed to assist radiologists in conducting primary diagnostic review for diagnostic and screening mammography through flexible and interactive manipulation of multi-modality softcopy images. It provides image review, manipulation, analysis, post-processing and printing capabilities that support image management display needs in the medical environment.
MammoWorkstation is designed to give easy and economic access to and display of multi-modality softcopy images, structured reports, and CAD results through interfaces to various image storage devices using DICOM or similar interface standards. It supports creation of structured reports according to the DICOM breast imaging report templates.
MammoWorkstation supports teleradiology and teleconferencing providing access to multi-modality softcopy images and structured reports in multiple locations within and outside the hospital.
Lossy compressed mammographic images must not be used for primary diagnostic interpretation unless approved for use in digital mammography.
Display monitors used for primary diagnostic interpretation of mammographic images must be approved for use in digital mammography.
All images sent to or imported in the MammoWorkstation must conform to regulatory requirements. Image quality must conform with applicable quality guidelines. All modalities must be certified for soft-copy reading.
Product codes
LLZ
Device Description
The MammoWorkstation is a medical image review workstation software for diagnostic and screening mammography. MammoWorkstation has the capability to review Digital Breast Tomosynthesis (DBT) images that are compatible with DICOM Breast Tomosynthesis Image Storage. A synthetized 2D image, called V-Preview, is generated from the GE DBT set by MammoWorkstation and can be displayed before or during the diagnostic interpretation review of the DBT set. It can be used for the pre-review of the DBT set or as additional image but does not replace the FFDM image. It is a software product.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
multi-modality softcopy images, Digital Breast Tomosynthesis (DBT) images, mammographic images
Anatomical Site
Breast
Indicated Patient Age Range
Not Found
Intended User / Care Setting
radiologists, medical environment, hospital
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Summary of Non-Clinical Tests: The MammoWorkstation and its applications comply with voluntary standards as detailed in Section 9, 11 and 17 of this premarket submission. The following quality assurance measures: Risk Analysis Requirements, Reviews, Design Reviews, Testing on unit level (Module verification), Integration testing (System verification), Performance testing (Verification), Safety testing (Verification), Simulated use testing (Validation).
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
MammoWorkstation (K123575)
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, with a series of lines above them that resemble a bird in flight.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
March 26, 2015
GE Healthcare % Mr. Mounir Zaouali Regulatory Affairs Leader Oskar-Schlemmer-Str. 11 Munich D-80807 GERMANY
Re: K143361
Trade/Device Name: MammoWorkstation Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: March 4, 2015 Received: March 9, 2015
Dear Mr. Zaouali:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
1
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Robert A Ochs
Robert Ochs, Ph.D. Acting Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K143361
Device Name MammoWorkstation
Indications for Use (Describe)
MammoWorkstation is designed to assist radiologists in conducting primary diagnostic review for diagnostic and screening mammography through flexible and interactive manipulation of multi-modality softcopy images. It provides image review, manipulation, analysis, post-processing and printing capabilities that support image management display needs in the medical environment.
MammoWorkstation is designed to give easy and economic access to and display of multi-modality softcopy images, structured reports, and CAD results through interfaces to various image storage devices using DICOM or similar interface standards. It supports creation of structured reports according to the DICOM breast imaging report templates.
MammoWorkstation supports teleradiology and teleconferencing providing access to multi-modality softcopy images and structured reports in multiple locations within and outside the hospital.
Lossy compressed mammographic images must not be used for primary diagnostic interpretation unless approved for use in digital mammography.
Display monitors used for primary diagnostic interpretation of mammographic images must be approved for use in digital mammography.
All images sent to or imported in the Mammoworkstation must conform to regulatory requirements. Image quality must conform with applicable quality guidelines. All modalities must be certified for soft-copy reading.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo for General Electric (GE). The logo is a blue circle with the letters "GE" in white inside. The letters are in a stylized font, and there are swirling lines around the letters. The logo is simple and recognizable.
GE Healthcare 510(k) Premarket Notification Submission
510(k) Summary
In accordance with 21 CFR 807.92 the following summary of information is provided:
| Date: | March 24, 2015 |
|---|---|
| Submitter: | GE Healthcare (Image Diagnost International) |
| Oskar-Schlemmer-Str. 11; | |
| 80807 München, Germany | |
| Primary Contact Person: | Mounir Zaouali, RAC |
| Regulatory Affairs Leader | |
| GE Healthcare, | |
| 283 RUE DE LA MINIERE | |
| 78530 BUC - FRANCE | |
| Phone : + 33 1 30 70 45 39 | |
| Fax : + 33 1 30 70 41 40 | |
| Mounir.Zaouali@ge.com | |
| Secondary Contact Person: | Gregory Pessato |
| Regulatory Affairs Leader | |
| GE Healthcare, | |
| 283 RUE DE LA MINIERE | |
| 78530 BUC - FRANCE | |
| Phone : + 33 1 30 70 93 16 | |
| Fax : + 33 1 30 70 41 40 | |
| Gregory.Pessato@ge.com | |
| Device Trade Name: | MammoWorkstation |
| Common/Usual Name: | Medical imaging software |
| Classification Names: | Picture archiving and communication system |
| Class II CFR 892.2050 System, Image Processing, Radiological, | |
| Product Code: | LLZ |
| Predicate Device(s): | MammoWorkstation (K123575) |
| Device Description: | The MammoWorkstation is a medical image review workstation |
| software for diagnostic and screening mammography. | |
| MammoWorkstation has the capability to review Digital Breast | |
| Tomosynthesis (DBT) images that are compatible with DICOM | |
| Breast Tomosynthesis Image Storage. | |
| A synthetized 2D image, called V-Preview, is generated from the | |
| GE DBT set by MammoWorkstation and can be displayed before | |
| or during the diagnostic interpretation review of the DBT set. It | |
| can be used for the pre-review of the DBT set or as additional | |
| image but does not replace the FFDM image. | |
| It is a software product | |
| Intended Use: | |
| MammoWorkstation is designed to assist radiologists in | |
| conducting primary diagnostic review for diagnostic and | |
| screening mammography through flexible and interactive | |
| manipulation of multi-modality softcopy images. | |
| It provides image review, manipulation, analysis, post-processing | |
| and printing capabilities that support image management display | |
| needs in the medical environment. | |
| MammoWorkstation is designed to give easy and economic | |
| access to and display of multi-modality softcopy images, | |
| structured reports, and CAD results through interfaces to various | |
| image storage devices using DICOM or similar interface | |
| standards. It supports creation of structured reports according to | |
| the DICOM breast imaging report templates. | |
| MammoWorkstation supports teleradiology and teleconferencing | |
| providing access to multi-modality softcopy images and | |
| structured reports in multiple locations within and outside the | |
| hospital. | |
| Lossy compressed mammographic images must not be used for | |
| primary diagnostic interpretation unless approved for use in | |
| digital mammography. | |
| Display monitors used for primary diagnostic interpretation of | |
| mammographic images must be approved for use in digital | |
| mammography. | |
| All images sent to or imported in the MammoWorkstation must | |
| conform to regulatory requirements. Image quality must conform | |
| with applicable quality guidelines. All modalities must be | |
| certified for soft-copy reading. | |
| Technology: | MammoWorkstation is software product. It is designed to run on |
| a standard workstation with a minimum of three monitors, one | |
| control monitor and high-resolution monitor (s) that are cleared | |
| for mammography review. | |
| It runs on Windows Operating System. | |
| Comparison of technological characteristics with the predicate | |
| device | |
| Adequate display and manipulation for the review of | |
| Mammography and DBT images are the technological principles | |
| for both the subject and predicate device. | |
| The main differences between the subject and the predicate | |
| device are : | |
| V-Preview images on the predicate device were used for pre- | |
| review of the breast before diagnostic review of the DBT set of | |
| images. | |
| To enhance the radiology workflow, the subject device has | |
| incorporated the following changes: | |
| The V-Preview images will be labeled as "2D: Synthesized" | |
| and | |
| "V-Preview | |
| For navigation use only | |
| does not replace FFDM" | |
| to distinguish them from non-synthesized images. | |
| V-Preview images can be annotated and printed or transferred | |
| to a PACS for storage or viewing in alternate locations. | |
| In addition to the standard MammoWorkstation configuration, | |
| V-Preview images can be generated by the DicomShuttle | |
| configuration. | |
| Determination of | |
| Substantial Equivalence: | Summary of Non-Clinical Tests: |
| The MammoWorkstation and its applications comply with | |
| voluntary standards as detailed in Section 9, 11 and 17 of this | |
| premarket submission. The following quality assurance measures |
4
Image /page/4/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters "GE" intertwined in a stylized, cursive font. The letters are enclosed within a circular border that has a swirling design around the perimeter. The logo is colored in a light blue hue.
GE Healthcare 510(k) Premarket Notification Submission
5
Image /page/5/Picture/0 description: The image shows the logo for General Electric (GE). The logo is a blue circle with the letters "GE" in a stylized font in the center. There are decorative swirls around the letters. The logo is simple and recognizable, and it is often used to represent the company.
GE Healthcare 510(k) Premarket Notification Submission
6
Image /page/6/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'GE' in a stylized, cursive font, enclosed within a circular shape. The logo is colored in a light blue hue. The logo is simple and recognizable.
GE Healthcare 510(k) Premarket Notification Submission
| Risk Analysis Requirements Reviews Design Reviews Testing on unit level (Module verification) Integration testing (System verification) Performance testing (Verification) Safety testing (Verification) Simulated use testing (Validation) | |
|---|---|
| Conclusion: | GE Healthcare considers the MammoWorkstation to be as safe, as effective, and performance is substantially equivalent to the predicate device. |